X
After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi
https://pharmaphorum.com/news/after-fda-approval-alkermes-plans-soft-launch-for-antipsychotic-lybalvi/
bipolar disorder
Allergan and Gedeon Richter set to expand use of bipolar drug
Companies want Vraylar as option bipolar depression
Report links Sanofi epilepsy drug with thousands of birth defects
Depakine and generics linked with defects including spina bifida.
Lundbeck/Otsuka look for new use of mental health drug
Companies want new bipolar disorder use for Abilify Maintena.